Reply: KRAS Status Analysis and Anti-Egfr Therapies: Is Comprehensiveness a Biologist's Fancy or a Clinical Necessity?
British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6605583
Full Text
Open PDFAbstract
Available in full text
Date
February 16, 2010
Authors
Publisher
Springer Science and Business Media LLC